Adam Feuerstein

ABT, Adam Feuerstein, After-Hours Center, Analyst Color, Analyst Ratings, Benzinga, CNBC, Coronavirus, Fast Money, General, GILD, Guy Adami, Health Care, MRK, News, remdesivir, SNY, STAT, Tim Seymour, Top stories, US0028241000, US3755581036, US58933Y1055, US80105N1054

Gilead’s Encouraging Remdesivir Data: Rapid Reaction On The Stock

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) gained more than 15% after Thursday’s market close and the encouraging report from STAT is “good news” although anecdotal, CNBC’

Latest Ratings for GILD
DateFirmActionFromTo Apr 2020Cantor FitzgeraldR…